Skip to content

Beneficiaries

Augmented Reality solutions for personalised in vitro treatments

Picture 1
Picture 2

Challenge

We are all different in unique ways, yet modern treatments ignore individuals’ genetic variations. People from different ethnicities, gender, ages are limited to take drugs based on a genetic set that is entirely different from their own. What if we could have the perfect medicine for each person? Unfortunately, biologists use animals and cells in plastic dishes to emulate the most complex system of all, the human body. They are missing accurate tools to handle that diversity. Bi/ond developed that tool. It is a computer chip, called organ-on-chip (OOC), where biologists can insert patient tissues. Those tissues are nourished, stimulated, and monitored by the chip, like in the human body. In this environment, it will be possible to test drugs on the patient’ cells, making sure they have the desired effect.

Solution

Developing patient cantered solutions requires overcoming barriers: Firstly, to create an OOC easy-to-learn for biologists and clinicians; secondly, analyse a large amount of data and create a comprehensive overview for patient automated diagnostic. Here is where the company weAR s.p.a comes in help with augmented reality solutions.

Achievements

In this Project, weAR and Bi/ond devloped the first-ever Organ-on-Chip AR platform (ARinBIO) able to:

  • fasten the learning curve of biologists and clinicians developing patience-specic treatments with OOC,
  • create a rapid communication channel between biologists and Bi/ond,
  • help biologists in collecting and visualising data obtained.

Impacts

By developing cutting-edge technologies easy to be used and accessible, we are paving the way toward personalized treatments available for all. 

Partners

Wear-Mobile

https://wear-mobile.com/

Italy

Go Biond

www.gobiond.com

Netherlands

Subscribe